Hem › Prostatacancer › District of Columbia › Washington
Kliniska studier för Prostatacancer i Washington, DC
38 studier för Prostatacancer söker deltagare vid platser i och runt Washington (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
RekryterarFas 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
The Vanguard Study: Testing a New Way to Screen for Cancer
RekryterarFriska volontärer välkomna
- Walter Reed National Military Medical Center, Bethesda · 7 mi bort
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
RekryterarObservationsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
RekryterarFas 3
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RekryterarObservationsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Collection of Blood From Patients With Prostate Cancer
RekryterarObservationsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekryterarObservationsstudieFriska volontärer välkomna
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi bort
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekryterarFas 2
- MedStar Georgetown University Hospital, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Precision-Based Genomics in Prostate Cancer
RekryterarObservationsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Collection of Blood From Patients With Cancer
RekryterarObservationsstudieFriska volontärer välkomna
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RekryterarFas 3
- MedStar Washington Hospital Center ( Site 0103), Washington D.C.
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
RekryterarObservationsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
RekryterarObservationsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
RekryterarFas 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
RekryterarFas 2
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
RekryterarFas 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
RekryterarFas 3
- The GW Medical Faculty Associates ( Site 0057), Washington D.C.
- Washington DC Veterans Affairs Medical Center ( Site 0056), Washington D.C.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RekryterarFas 3
- George Washington University Medical Center, Washington D.C.
- UM Capital Region Medical Center, Largo · 11 mi bort
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
RekryterarObservationsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
RekryterarFas 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Men at High Genetic Risk for Prostate Cancer
RekryterarObservationsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
RekryterarFas 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
Rekryterar
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer
RekryterarFas 2
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RekryterarFas 3
- Sibley Memorial Hospital, Washington D.C.
- Suburban Hospital, Bethesda · 7 mi bort
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
RekryterarFas 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RekryterarFas 3
- Sibley Memorial Hospital, Washington D.C.
- George Washington University Medical Center, Washington D.C.
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
RekryterarFas 1
- Maryland Oncology Hematology, Silver Spring · 7 mi bort
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
RekryterarObservationsstudieFriska volontärer välkomna
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
RekryterarFas 4
- VA Medical Center, Washington D.C.
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
RekryterarObservationsstudieFriska volontärer välkomna
- Cancer Support Community Research & Training Institute, Washington D.C.
Clinical Trial of Approaches to Prostate Cancer Surgery
Rekryterar
- Georgetown University, Washington D.C.
Castrate Resistant Prostate Cancer Enhertu Therapy
RekryterarFas 2
- Washington DC VAMC, Washington D.C.
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
RekryterarFas 2/3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
RekryterarFriska volontärer välkomna
- Howard University Hospital, Washington D.C.
- National Cancer Institute, Bethesda · 7 mi bort
- Walter Reed National Military Medical Center, Bethesda · 7 mi bort
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi bort
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi bort
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RekryterarFas 3
- George Washington University Medical Center, Washington D.C.
Prostatacancer-studier i andra städer
- New York City, NY103 studier
- Houston, TX76 studier
- Los Angeles, CA61 studier
- Boston, MA59 studier
- St. Louis, MO46 studier
- Chicago, IL45 studier
- San Francisco, CA45 studier
- Philadelphia, PA44 studier
- Baltimore, MD43 studier
- Nashville, TN43 studier
- Seattle, WA42 studier
- Dallas, TX36 studier
Andra studier i Washington
- Cancer (alla typer)58 studier
- Icke-småcellig lungcancer55 studier
- Bröstcancer46 studier
- Metastaserande cancer43 studier
- Lungcancer41 studier
- Övervikt33 studier
- Kolorektal cancer29 studier
- Hjärt-kärlsjukdom28 studier
- Blåscancer26 studier
- Akut myeloid leukemi24 studier
- Äggstockscancer23 studier
- Lymfom23 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.